IGI receives CIRM Inception Award to study mechanisms in blood cancers

The IGI has been awarded a CIRM Inception Award to use gene editing in bone marrow stem cells in order to discover mechanisms that lead to certain types of blood cancers.  The CIRM Inception Awards provide seed funding to support the exploration of transformational ideas that hold the potential to greatly impact the field of human stem cell research.  The IGI will use genetic engineering to determine how mutations frequently observed in the bone marrow stem cells of patients lead to a family of diseases called meyloproliferative neoplasms (MPNs).  The MPN disorders are characterized by over-production of certain blood cells, such as red blood cells or platelets, but it is unclear how patient mutations cause these disorders.  A better understanding of how MPN-associated mutations lead to disease could eventually lead to better therapies for patients suffering from MPN.

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

July 9, 2024

CCAR1 PROMOTES DNA REPAIR VIA ALTERNATIVE SPLICING – PUBLISHED IN MOLECULAR CELL

Cells constantly experience DNA damage throughout their lifespan due to a variety of endogenous and exogenous factors. Among the different types of DNA damage,...

July 1, 2024

Latsis Symposium on Genome and Transcriptome Engineering 2024

The Latsis Symposium on Genome and Transcriptome Engineering, held on June 13-14, 2024 in Zurich, was a remarkable event! This dynamic two-day gathering ...

July 1, 2024

D-BIOL Symposium 2024

From June 10-12, 2024, the Corn Lab members attended the 14th D-BIOL Symposium in Davos. This exciting biannual internal ETHZ event brought together nearly...

News Archive

Tweets